Rgenta Therapeutics, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2018-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.rgentatx.com
Study of Safety and Efficacy of RGT-61159 in Adults with Relapsed/Refractory Adenoid Cystic Carcinoma (ACC) or Colorectal Carcinoma (CRC)
- First Posted Date
- 2024-06-17
- Last Posted Date
- 2024-12-10
- Lead Sponsor
- Rgenta Therapeutics Inc
- Target Recruit Count
- 105
- Registration Number
- NCT06462183
- Locations
- 🇺🇸
University of Michigan, Ann Arbor, Michigan, United States
🇺🇸Dana-Farber Cancer Institute, Boston, Massachusetts, United States
🇺🇸Washington University School of Medicine, St Louis, Missouri, United States
© Copyright 2025. All Rights Reserved by MedPath